Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)

Initial prescriptions will be 99 cents for a one month supply with refills starting at $79 per month, including shipping SAN DIEGO, Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmol... Biopharmaceuticals, Ophthalmology, Product Launch Imprimis Pharmaceuticals, Cyclosporine, Restasis, Dry Eye
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news